Cambridge, USA-based biotech Avalyn Pharma, which developing inhaled therapies for the treatment of life-threatening pulmonary diseases, has announced the closing of an oversubscribed $100 million ...

COVID-19 surge in the US! Find out why cases are increasing and get expert advice on how to protect yourself and loved ones.